Investigación / Grupos de investigación

Grupo  401

Microbiología clínica y enfermedades Infecciosas

Publicaciones (1284)

  • Burillo, A; Bouza, E.

    The evolution of knowledge for treating Gram-negative bacterial infections

    CURRENT OPINION IN INFECTIOUS DISEASES. 2024; 37(6): 573-581 Nº de citas: 1 [doi:10.1097/QCO.0000000000001055]

  • Calderón-Parra, J; Grillo, S; Muñoz, P; Machado-Vilchez, M; Delgado-Montero, A; De Alarcón-González, A; Poyato-Borrego, M; Goenaga-Sánchez, M; Fariñas-Alvarez, MC; Miró, JM; López-Cortés, LE; Rodríguez-García, R; Oteo, JA; Martínez-Ramos, A.

    Efficacy and safety of antistaphylococcal penicillin or cephazolin-based combinations versus monotherapy for methicillin-susceptible Staphylococcus aureus infective endocarditis: A propensity score analysis of nationwide prospective cohort

    JOURNAL OF INFECTION. 2024; 89(6): Nº de citas: 5 [doi:10.1016/j.jinf.2024.106352]

  • Piñeiro, P; Calvo, A; Pérez-Díaz, MD; Ramos, S; García-Ramos, S; Power, M; Solchaga, I; Rey, C; Hortal, J; Turégano, F; Garutti, I.

    Early Thrombocytopenia at Hospital Admission Predicts Mortality in Patients with Non-Isolated Severe Traumatic Brain Injury

    Biomedicines. 2024; 12(12): Nº de citas: 1 [doi:10.3390/biomedicines12122702]

  • Martín-Delgado, MC; Ramos, PD; Garcia-Botella, A; Cantón, R; García-Lledó, A; Hernández-Sampelayo, T; Gómez-Pavon, J; del Castillo, JG; Sánchez, FJM; Martínez-Sellés, M; Garcia, JMM; Guillén, SM; Rodríguez-Artalejo, F; Ruiz-Galiana, J; Burillo, A; Muñoz, P; Rey, CC; Catalán-González, M; Cendejas-Bueno, E; Halperin-Benito, AV; Recio, R; Vinuela-Benitez, C; Bouza, E.

    Invasive group A Streptococcus infection ( Streptococcus pyogenes): Current situation in Spain

    Revista Espanola de Quimioterapia. 2024; 37(6): Nº de citas: 4 [doi:10.37201/req/067.2024]

  • Márquez-Gómez, M; Díaz-Navarro, M; Visedo, A; Prats-Peinado, L; Muñoz, P; Vaquero, J; Guembe, M; Sanz-Ruíz, P.

    Does a Specific Sequential Combination of Antiseptic Solutions for Chemical Debridement in Periprosthetic Joint Infection Improve Outcomes vs. Solution Alone? An In Vivo Study

    Antibiotics-Basel. 2024; 13(12): Nº de citas: 3 [doi:10.3390/antibiotics13121225]

  • Candela, A; Rodríguez-Temporal, D; Lumbreras, P; Guijarro-Sánchez, P; Arroyo, MJ; Vázquez, F; Beceiro, A; Bou, G; Muñoz, P; Oviaño, M; Fernández, J; Rodríguez-Sánchez, B.

    Multicenter evaluation of Fourier transform infrared (FTIR) spectroscopy as a first-line typing tool for carbapenemase-producing Klebsiella pneumoniae in clinical settings

    JOURNAL OF CLINICAL MICROBIOLOGY. 2024; 63(1): Nº de citas: 6 [doi:10.1128/jcm.01122-24]

  • Mesquida, A; Martín-Rabadán, P; Alcalá, L; Burillo, A; Reigadas, E; Muñoz, P; Guinea, J; Escribano, P.

    Candida spp. colonization: a genotype source found in blood cultures that can become widespread

    Frontiers in Cellular and Infection Microbiology. 2024; 14: Nº de citas: 5 [doi:10.3389/fcimb.2024.1468692]

  • Guinea, J; Alcoceba, E; Padilla, E; Ramírez, A; De Carolis, E; Sanguinetti, M; Muñoz-Algarra, M; Durán-Valle, T; Quiles-Melero, I; Merino, P; González-Romo, F; Sánchez-García, A; Gómez-García-de-la-Pedrosa, E; Pérez-Ayala, A; Mantecon-Vallejo, MA; Pemán, J; Cuétara, MS; Zurita, ND; García-Esteban, C; Martínez-Jiménez, MD; Castellano, MAS; Reigadas, E; Muñoz, P; Escribano, P.

    Fluconazole-resistant Candida parapsilosis: fast detection of the Y132F ERG11p substitution, and a proposed microsatellite genotyping scheme

    CLINICAL MICROBIOLOGY AND INFECTION. 2024; 30(11): 1447-1452 Nº de citas: 8 [doi:10.1016/j.cmi.2024.07.002]

  • Escribano, P; Cuéllar, LA; Alvarez-Gutiérrez, A; Muñoz, P; Guinea, J.

    Detecting Echinocandin Resistance in C. glabrata Using Commercial Methods: Are CLSI or EUCAST Breakpoints Suitable for Categorical Classification?

    MYCOSES. 2024; 67(11): [doi:10.1111/myc.70003]

  • Garcia-Hernandez, S; Higuero-Cantonero, F; Garcia, FD; Chico, AA; Aceituno, JB; Garcia, SZ; Godoy, JLA; Iglesias, JH; Perez, AEL; Garutti, I.

    Predicting Responses to Interventional Pain Management Techniques for Chronic Low Back Pain: A Single-Center Observational Study (PReTi-Back Study

    Pain Physician. 2024; 27(8):

  • Garcia-Hernandez S; Higuero-Cantonero F; de la Gala Garcia F; Alonso Chico Á; Blanco Aceituno J; Zapatero Garcia S; Aguilar Godoy JL; Hortal Iglesias J; Lopez Perez AE; Garutti I.

    Predicting Responses to Interventional Pain Management Techniques for Chronic Low Back Pain: A Single-Center Observational Study (PReTi-Back Study).

    Pain Physician. 2024; 27(8):

  • de la Villa, S; Sánchez-Martínez, C; Cercenado, E; Padilla, B; Vicente, T; Serrano, J; Urbina, L; Muñoz, P.

    Effectiveness of short treatment duration for carbapenemase-producing Enterobacterales in bloodstream-infections: A retrospective cohort study

    International Journal of Antimicrobial Agents. 2024; 64(5): Nº de citas: 3 [doi:10.1016/j.ijantimicag.2024.107318]

  • Benjumea-Carrasco, A; Guembe, M; Díaz-Navarro, M; Muñoz, P; Vaquero-Martin, J; Chana-Rodriguez, F.

    The role of tranexamic acid for infection prevention after fracture fixation

    INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED. 2024; 55: Nº de citas: 1 [doi:10.1016/j.injury.2024.111846]

  • Fernández-Ruiz, M; Gioia, F; Bodro, M; Martín, I; Sabé, N; Rodriguez-alvarez, R; Corbella, L; López-Viñau, T; Valerio, M; Illaro, A; Salto-Alejandre, S; Cordero, E; Arnaiz de Las Revillas, F; Fariñas, M; Muñoz, P; Vidal, E; Carratalà, J; Goikoetxea, J; Ramos-Martínez, A; Moreno, A; Martín-Dávila, P; Fortún, J; Aguado, J.

    Isavuconazole Versus Voriconazole as the First-line Therapy for Solid Organ Transplant Recipients With Invasive Aspergillosis: Comparative Analysis of 2 Multicenter Cohort Studies

    TRANSPLANTATION. 2024; 108(11): 2260-2269 Nº de citas: 4 [doi:10.1097/TP.0000000000005082]

  • Félix, J; Baca, A; Taboada, L; Alvarez-Calatayud, G; de la Fuente, M.

    Consumption of a Probiotic Blend with Vitamin D Improves Immunity, Redox, and Inflammatory State, Decreasing the Rate of Aging-A Pilot Study

    Biomolecules. 2024; 14(11): Nº de citas: 4 [doi:10.3390/biom14111360]

  • Bassy Navarro, S.; Gil Villanueva, N.; Camino-López, M.; Alonso Fernández, R.; Lázaro-Martín, B.; Hernanz-Lobo, A.; Navarro Gómez, M..

    Importance of optimizing routine immunization schedules in pediatric heart transplantation

    Vacunas. 2024; 25(4): 454-461 [doi:10.1016/j.vacun.2024.07.002]

  • Irigoyen-von-Sierakowski, A; Ocaña, A; Sanchez-Mayoral, R; Cercenado, E.

    Real-world performance of susceptibility testing for cefiderocol: insights from a prospective multicentre study on Gram-negative bacteria

    JAC-Antimicrobial Resistance. 2024; 6(5): Nº de citas: 7 [doi:10.1093/jacamr/dlae169]

  • Fernández-Ruiz M; Castón JJ; Del Pozo JL; Carratalà J; Fortún J; Salavert M; Torre-Cisneros J; Aguado JM; Fernández Cruz A; Ventura A; Loeches B; Dueñas C; Tomás C; Navarro D; Oltra R; Resino-Foz E; García Vázquez E; Míguez E; Merino E; Braojos F; Martínez FJ; López-Medrano Pérez F; Machuca I; Cobo J; López Contreras J; Reguera JM; Ruiz Mesa JD; Tiraboschi J; Abella L; Masiá M; Del Toro López MD; Díaz López MD; Carrasco-Antón N; Merchante N; Muñoz P; Torres R; Rodríguez R; Mata-Forte T; Abril V.

    How can we optimize the diagnostic and therapeutic approach to pneumonia? Expert opinion-based recommendations.

    Enfermedades Infecciosas Y Microbiologia Clinica (english Ed.). 2024; 42(8): 442-452 Nº de citas: 5 [doi:10.1016/j.eimce.2024.07.001]